Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Mov Disord. 2017 Nov;32(11):1504–1523. doi: 10.1002/mds.27193

Table 3.

Summary of LRRK2 autopsy reports

Report Autopsies (n) Genotype (n) Phenotype (n) Pattern of Neuronal Loss LB, LN Pathology (n) LB Distribution– Braak Stage (n) Tau Pathology– NFT Stage (n) Other Inclusions (n)
Gilks et al., 2005148 3 G2019S (3) PD (3) SNpc, LC 3 3 (1) 4 (2) Sparse (1) − (2)
Gaig et al., 2008149; Gaig et al., 2007150; Gomez and Ferrer, 2010151 3 G2019S (3) PD (3) SNpc, LC + (2) − (1) 4 (1) 5 (1) − (1) I (1) II (1) III (1)
Rajput et al., 2006152 1 G2019S (1) PD (1) SNpc mild − (1) IV (1) PSP-like
Ross et al., 2006137 10 G2019S (10) PD (8) dementia (3/8), cognitive decline (2/8) AD (1) control (1) SNpc, LC + (8) − (2) 3 (4) 4 (3) 6 (1) − (2) − (3) I (1) III (4) AD (2)
Giasson et al., 2006153 3 G2019S (3) EOPD (1), PD (2) dementia (1/3) SNpc, LC + (2) − (1) 4 (1) 5 (1) − (1) I (1) III (1) AD (1)
Dachsel et al., 2007154 1 G2019S (1) Dementia (1) Hippocampus − (1) − (1) − (1) FTD-U
Silveira-Moriyama et al., 2008155 4 G2019S (4) PD (4) SNpc, LC, olfactory bulb 4 5 (4) II (4) Olfactory bulb LBs (4)
Poulopoulos et al., 2012156 3 G2019S (3) EOPD (2), PD (1) dementia (2/3) SNpc, LC 3 4 (2) 6 (1) Sparse (2) AD (1)
Kalia et al 201522 2 a, b, c G2019S n.d. n.d. + (2), − (1) n.d. − (3); βAPs present (3)
Vilas et al. 2016157 2 G2019S (2) PSP (1) Severe GP, SNpc, subthalamic nucleus Absent LBs; no alpha-synuclein n/a Neuronal and glial subcortical 4-repeat tau pTau-positive tufted astrocytes; grade A3, B2, C2 AD pathology; No TDP43; coiled bodies; Globose neuronal tangles
PD (1) LBS in cingulate and temporal cortices, amygdala, basal forebrain, SNpc, NC coiled bodies; tufted astrocytes; Globose neuronal tangles
Wszolek et al., 2004158, Zimprich et al., 200423, Wider et al., 2010159 6 R1441C (4) Y1699C (2) PD (6) SNpc LC + (2/4 R1441C) − (4) 4 (1) 6 (1) − (4) Sparse (1), AD (1 Y1699C), − (4) PSP-like in 1 (R1441C); TDP-43 in SNpc neurites in 1 (R1441C)
Khan et al., 2005160 1 Y1699C PD (1) SNpc, LC 1 3 (1) II (1) Olfactory bulb LBs
Giordana et al., 2007161 1 I1371V (1) PD cognitive decline (1) SNpc>LC 1 4 (1) II (1)
Covy et al., 2009162 2 R793M (1) L1165P (1) PD (2) dementia (1/2) SNpc, LC 2 4 (2) II (1) III (1) TDP-43 in TC (2)
Gaig et al., 2008149 1 R1441R PD dementia (1) SNpc 1 n.d. n.d.
Hasegawa et al., 2009163; Hasegawa and Kowa, 1997164 8 I2020T (8) PD (8) SNpc, SNpr, LC spared − (7) + (1) − (7) 3 (1) − (8) GCI (1)
Marti-Masso et al., 2009165 1 R1441G PD (1) SNpc>LC − (1) I (1) a-B crystalline in SN
Puschmann et al., 2011130 1 N1437H (1) PD (1) SNpc>LC 1 5 (1) Sparse (1) Diffuse, atypical ubiquitin+ inclusions
Kalia et al.22, 2015 1 d R1441G n.d. n.d. − (1) n.d. − (1)

G2019S mutation carriers are shaded in light gray. Abbreviations: PD = Parkinson’s disease; EOPD = early onset Parkinson’s disease; PSP = progressive supranuclear palsy; FTD-U = frontotemporal dementia with ubiquitin inclusions; LB = Lewy bodies; LN = Lewy neurites; βAPs = β-amyloid plaques; GCI = glial-cytoplasmic inclusions; GP = globus pallidus; SNpc = substantia nigra pars compacta; SNpr = substantia nigra pars reticulata; LC = locus coeruleus; TC = temporal cortex.

a

Case provided by SM Goldman, B Schüle, J Langston (The Parkinson’s Institute, Sunnyvale, CA, USA)

b

Case provided by J Aasly (University of Trondheim, Trondheim, Norway; c: Case provided by AE Lang, L Hazrati

C

Marras (University of Toronto, Toronto, Canada)

d

Case provided by J Ruiz-Martinez, J Marti Masso, (Hospital Universitario Donostia, CIBERNED, San Sebastián, Spain)